PMC:7189872 / 2380-2864 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"60","span":{"begin":227,"end":237},"obj":"Species"},{"id":"61","span":{"begin":360,"end":366},"obj":"Species"},{"id":"62","span":{"begin":445,"end":455},"obj":"Species"}],"attributes":[{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:2697049"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Tax:9606"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":227,"end":231},"obj":"Disease"},{"id":"T12","span":{"begin":445,"end":449},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T24","span":{"begin":15,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T25","span":{"begin":238,"end":243},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T26","span":{"begin":360,"end":366},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T27","span":{"begin":384,"end":387},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":411,"end":418},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":332,"end":356},"obj":"http://purl.obolibrary.org/obo/GO_0002250"},{"id":"T2","span":{"begin":341,"end":356},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"LitCovid-sentences","denotations":[{"id":"T22","span":{"begin":76,"end":244},"obj":"Sentence"},{"id":"T23","span":{"begin":245,"end":367},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T42","span":{"begin":50,"end":58},"obj":"GO:0065007"},{"id":"T43","span":{"begin":200,"end":206},"obj":"UBERON:0002405"},{"id":"T44","span":{"begin":207,"end":214},"obj":"GO:0006952"},{"id":"T45","span":{"begin":227,"end":237},"obj":"SP_7"},{"id":"T46","span":{"begin":238,"end":243},"obj":"NCBITaxon:10239"},{"id":"T47","span":{"begin":332,"end":340},"obj":"GO:0002250"},{"id":"T48","span":{"begin":341,"end":347},"obj":"GO:0002250;UBERON:0002405"},{"id":"T49","span":{"begin":348,"end":356},"obj":"GO:0002250"},{"id":"T50","span":{"begin":360,"end":366},"obj":"NCBITaxon:9606"},{"id":"T51","span":{"begin":411,"end":418},"obj":"BV_9"},{"id":"T52","span":{"begin":445,"end":455},"obj":"SP_7"},{"id":"T67003","span":{"begin":50,"end":58},"obj":"GO:0065007"},{"id":"T1865","span":{"begin":200,"end":206},"obj":"UBERON:0002405"},{"id":"T54457","span":{"begin":207,"end":214},"obj":"GO:0006952"},{"id":"T44230","span":{"begin":227,"end":237},"obj":"SP_7"},{"id":"T59713","span":{"begin":238,"end":243},"obj":"NCBITaxon:10239"},{"id":"T40650","span":{"begin":332,"end":340},"obj":"GO:0002250"},{"id":"T91359","span":{"begin":341,"end":347},"obj":"GO:0002250;UBERON:0002405"},{"id":"T56571","span":{"begin":348,"end":356},"obj":"GO:0002250"},{"id":"T12847","span":{"begin":360,"end":366},"obj":"NCBITaxon:9606"},{"id":"T48897","span":{"begin":411,"end":418},"obj":"BV_9"},{"id":"T2196","span":{"begin":445,"end":455},"obj":"SP_7"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}

{"project":"2_test","denotations":[{"id":"32352026-32081636-47638063","span":{"begin":71,"end":73},"obj":"32081636"},{"id":"T7572","span":{"begin":71,"end":73},"obj":"32081636"}],"text":"til now, there has been no efficacious therapy to regulate its spread [24]. Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome o"}